BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22327936)

  • 21. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
    Naito Y; Yasuno K; Tagawa H; Sakamoto N; Oue N; Yashiro M; Sentani K; Goto K; Shinmei S; Oo HZ; Yanagihara K; Hirakawa K; Yasui W
    Oncol Rep; 2014 Oct; 32(4):1720-6. PubMed ID: 25051317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.
    Namiki Y; Namiki T; Yoshida H; Date M; Yashiro M; Matsumoto K; Nakamura T; Yanagihara K; Tada N; Satoi J; Fujise K
    Int J Cancer; 2006 Mar; 118(6):1545-55. PubMed ID: 16206271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
    Yashiro M; Matsuoka T; Ohira M
    Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells.
    Kushiyama S; Yashiro M; Yamamoto Y; Sera T; Sugimoto A; Nishimura S; Togano S; Kuroda K; Okuno T; Miki Y; Ohira M
    Anticancer Res; 2022 Jan; 42(1):501-509. PubMed ID: 34969760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic characteristics of scirrhous gastric carcinomas].
    Yokozaki H; Kuniyasu H; Yasui W; Tahara E
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2371-7. PubMed ID: 7944479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.
    Matsuzaki T; Yashiro M; Kaizaki R; Yasuda K; Doi Y; Sawada T; Ohira M; Hirakawa K
    Cancer Sci; 2009 Dec; 100(12):2402-10. PubMed ID: 19764996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of HLA-A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer.
    Iwauchi T; Tanaka H; Yamazoe S; Yashiro M; Yoshii M; Kubo N; Muguruma K; Sawada T; Ohira M; Hirakawa K
    Cancer Sci; 2011 Apr; 102(4):683-9. PubMed ID: 21205089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
    Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Uraoka N; Oshima T; Yanagihara K; Oue N; Yasui W
    Oncol Rep; 2014 Jul; 32(1):403-10. PubMed ID: 24807047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation.
    Kikuchi Y; Kunita A; Iwata C; Komura D; Nishiyama T; Shimazu K; Takeshita K; Shibahara J; Kii I; Morishita Y; Yashiro M; Hirakawa K; Miyazono K; Kudo A; Fukayama M; Kashima TG
    Am J Pathol; 2014 Mar; 184(3):859-70. PubMed ID: 24418260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytophotometric analysis on nuclear DNA contents of human scirrhous gastric carcinoma.
    Oda N; Tahara E; Taniyama K
    Pathol Res Pract; 1989 Apr; 184(4):390-401. PubMed ID: 2542909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
    Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
    Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel germ line juxtamembrane Met mutation in human gastric cancer.
    Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
    Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis.
    Lemieux E; Bergeron S; Durand V; Asselin C; Saucier C; Rivard N
    Int J Cancer; 2009 Oct; 125(7):1575-86. PubMed ID: 19462441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of
    Schmidt J; Ramis-Zaldivar JE; Nadeu F; Gonzalez-Farre B; Navarro A; Egan C; Montes-Mojarro IA; Marafioti T; Cabeçadas J; van der Walt J; Dojcinov S; Rosenwald A; Ott G; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2017 Jul; 130(3):323-327. PubMed ID: 28533310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Map2k1 and Map2k2 genes contribute to the normal development of syncytiotrophoblasts during placentation.
    Nadeau V; Guillemette S; Bélanger LF; Jacob O; Roy S; Charron J
    Development; 2009 Apr; 136(8):1363-74. PubMed ID: 19304888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q 12.2.
    Nishioka N; Yashiro M; Inoue T; Matsuoka T; Ohira M; Chung KH
    Int J Oncol; 2001 Feb; 18(2):317-22. PubMed ID: 11172598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
    Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
    Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.
    Greulich H; Chen TH; Feng W; Jänne PA; Alvarez JV; Zappaterra M; Bulmer SE; Frank DA; Hahn WC; Sellers WR; Meyerson M
    PLoS Med; 2005 Nov; 2(11):e313. PubMed ID: 16187797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.